Post-approval studies (Phase 4)Study completedNCT00568074
What this trial is testing
Efficacy and Safety of Repaglinide, Glurenorm® and Glucobay® in Chinese Subjects With Type 2 Diabetes
Who this might be right for
DiabetesDiabetes Mellitus, Type 2
Novo Nordisk A/S 131